Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 52Leukemia, Myeloid, Acute 51Myelodysplastic Syndromes 45Leukemia 34Lymphoma, Non-Hodgkin 33Lymphoma 28Leukemia, Myelogenous, Chronic, BCR-ABL Positive 24Hematologic Neoplasms 20Breast Neoplasms 19Hodgkin Disease 18Leukemia, Lymphocytic, Chronic, B-Cell 16Burkitt Lymphoma 15Multiple Myeloma 13Neuroblastoma 12Lymphoma, Large B-Cell, Diffuse 12Leukemia, Myeloid, Accelerated Phase 12Leukemia, Biphenotypic, Acute 11Central Nervous System Neoplasms 11Blast Crisis 11Lymphoma, Large-Cell, Immunoblastic 10Lymphoma, Follicular 10Graft vs Host Disease 10Dendritic Cell Sarcoma, Interdigitating 10Anemia, Refractory, with Excess of Blasts 10Recurrence 9Myeloproliferative Disorders 9Medulloblastoma 9Lymphoma, Mantle-Cell 9Leukemia, Myeloid, Chronic-Phase 9Congenital Abnormalities 9

Interventions

fludarabine phosphate 1Whole-Body Irradiation 1Thiotepa 1Standard of Care 1Melphalan 1Cyclophosphamide 1Clinical Trials, Phase I as Topic 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Metabolism, Inborn Errors × Thiotepa × Clear all
NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡